In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Cytek BioSciences Inc (NASDAQ: CTKB) was $5.67 for the day, up 0.35% from the previous closing price of $5.65. In other words, the price has increased by $0.35 from its previous closing price. On the day, 0.62 million shares were traded. CTKB stock price reached its highest trading level at $5.685 during the session, while it also had its lowest trading level at $5.48.
Ratios:
Our analysis of CTKB’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.69 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 67.91. For the most recent quarter (mrq), Quick Ratio is recorded 6.38 and its Current Ratio is at 7.33. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on December 14, 2023, initiated with a Overweight rating and assigned the stock a target price of $9.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 19 ’24 when Yan Ming sold 20,000 shares for $5.87 per share. The transaction valued at 117,400 led to the insider holds 5,988,502 shares of the business.
Yan Ming sold 1,900 shares of CTKB for $13,304 on Apr 09 ’24. The CHIEF TECHNOLOGY OFFICER now owns 6,008,502 shares after completing the transaction at $7.00 per share. On Mar 18 ’24, another insider, Yan Ming, who serves as the CHIEF TECHNOLOGY OFFICER of the company, sold 20,000 shares for $6.77 each. As a result, the insider received 135,400 and left with 6,030,402 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CTKB now has a Market Capitalization of 745639040 and an Enterprise Value of 482201696. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.77 while its Price-to-Book (P/B) ratio in mrq is 1.92. Its current Enterprise Value per Revenue stands at 2.439 whereas that against EBITDA is -27.695.
Stock Price History:
Over the past 52 weeks, CTKB has reached a high of $9.87, while it has fallen to a 52-week low of $3.80. The 50-Day Moving Average of the stock is -2.59%, while the 200-Day Moving Average is calculated to be -16.68%.
Shares Statistics:
CTKB traded an average of 662.53K shares per day over the past three months and 556180 shares per day over the past ten days. A total of 130.71M shares are outstanding, with a floating share count of 119.18M. Insiders hold about 9.37% of the company’s shares, while institutions hold 57.53% stake in the company. Shares short for CTKB as of 1722384000 were 5465573 with a Short Ratio of 8.25, compared to 1719532800 on 6445857. Therefore, it implies a Short% of Shares Outstanding of 5465573 and a Short% of Float of 5.3200003.
